Dr. Rafiq Zakaria Campus, Department of Pharmaceutical Chemistry, Y. B. Chavan College of Pharmacy, Aurangabad 431001, M.S., India.
Dr. Rafiq Zakaria Campus, Department of Pharmaceutical Chemistry, Y. B. Chavan College of Pharmacy, Aurangabad 431001, M.S., India.
Bioorg Med Chem Lett. 2014 May 1;24(9):2155-8. doi: 10.1016/j.bmcl.2014.03.030. Epub 2014 Mar 21.
The present study was undertaken to evaluate in-vivo hypolipidemic activity of a novel series of 2-methyl-2-(substituted phenyl isoxazol)phenoxyacetic acid derivatives by triton induced hyperlipidemia in rats. The newly synthesized compounds 5a, 5d and 5g showed significant decrease in the serum TCH, TG, LDL and VLDL along with an increase in serum HDL levels as compared to standard drug Fenofibrate. The treated groups also showed significant decrease in the atherogenic index and increase in % protective activity compared to control group.
本研究旨在评估一系列新型 2-甲基-2-(取代苯基异恶唑)苯氧乙酸衍生物的体内降血脂活性,采用 Triton 诱导的大鼠高血脂模型。与标准药物非诺贝特相比,新合成的化合物 5a、5d 和 5g 能显著降低血清总胆固醇(TCH)、甘油三酯(TG)、低密度脂蛋白(LDL)和极低密度脂蛋白(VLDL)水平,同时增加血清高密度脂蛋白(HDL)水平。与对照组相比,治疗组的动脉粥样硬化指数也显著降低,保护活性增加。